Verona pharma investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates adequacy of price and process in proposed sale of verona pharma plc - vrna

New york & new orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of verona pharma plc (nasdaqgm: vrna) to merck & co., inc. (nyse: mrk). under the terms of the proposed transaction, shareholders of verona will receive $107.00 in cash for each share of american depository share that they own. ksf is seeking to determine whether this consideration and the process.
VRNA Ratings Summary
VRNA Quant Ranking